The Specialized Program of Research Excellence in Ovarian Cancer award from the National Cancer Institute has been granted to the Roswell Park Cancer Institute and University of Pittsburgh Cancer Institute. According to a press release, the grant will provide more than $11 million over 5 years.
The grants are awarded to leading centers that demonstrate excellence in research, specifically with the potential to affect and improve patient care and prevention.
Nationwide, only four other SPORE grants focus on ovarian cancer; the collaboration between Roswell Park and the University of Pittsburgh marks the fifth.
Research conducted by the two groups will be broken down into four projects and will include three treatment studies and one genetic epidemiological study using the clinical and basic science expertise of both institutions.